Has Ranjana Sinha received payments from drug or device companies?

Yes. Drug and device makers reported $1,632 in general payments to Ranjana Sinha across 91 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ranjana Sinha did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ranjana Sinha come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ranjana Sinha

Pediatrics · Columbus, OHNPI 1053442905

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 29.2% of the total. 2025 is the largest year on record at $710, 2.2 times the $325 reported in 2019. Among pediatrics clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,632in general payments, 2019–2025

Across 91 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$476
Tris Pharma Inc$271
Organon$180
Corium, LLC$127
Merck$103
Seqirus USA Inc$96
plus $381 from 13 others

What the payments were for

Food & beverage$1,632100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	39	$476
Tris Pharma Inc	14	$271
Organon	2	$180
Corium, LLC	5	$127
Merck	5	$103
Seqirus USA Inc	4	$96
Neos Therapeutics, LP	3	$56
Biomarin Pharmaceutical Inc.	2	$44
Sanofi-aventis U.S. LLC	2	$40
Cranial Technologies, Inc	2	$38
Sobi, Inc	2	$35
Vertical Pharmaceuticals, LLC	2	$33
Kowa Pharmaceuticals America, Inc.	2	$29
Sanofi Pasteur Inc.	2	$25
Adlon Therapeutics L.p.	1	$21
GSK	1	$17
Shire North American Group Inc	1	$16
Pfizer	1	$14
Phadia US Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,632 in reported general payments places this provider in the 90th percentile of 2,041 pediatrics providers in Ohio.

See all pediatrics providers in Ohio →

Other pediatrics in Columbus

Patricia GravesColumbus$9K
Mitchell CampColumbus$4K
Emily FergusonColumbus$4K
Amy GareeColumbus$4K
Steven BrownColumbus$4K
Ryan BodeColumbus$3K
Jon DvorakPerrysburg$212K
Charles DebrosseCincinnati$135K
Scott WexelblattCincinnati$64K
Breanne RocheSolon$58K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →